final approval by USFDA to make cheaper versions of Valcyte. The company is expected to launch the drug shortly in the US market. ROC questions Plethico Pharmaceuticals over complaints from investors on the fixed deposit schemes The Registrar of Companies (ROC)‚Gwalior is inspecting the books of accounts of the Indore-based Plethico Pharmaceuticals‚ following hundreds of complaints received by the investor grievance cell of the corporate affairs ministry for almost a year. The investors claimed that
Premium Food and Drug Administration Generic drug Pharmaceutical industry
2015 www.hbr.org Industries follow distinctive change trajectories. Investments in innovation are more likely to pay off if you take those pathways into account. How Industries Change by Anita M. McGahan Reprint R0410E This document is authorized for use only in Strategic Management (Section-C&E) by Prof. Sushil Khanna‚ at Indian Institute of Management - Calcutta from January 2015 to March 2015. For exclusive use at Indian Institute of Management - Calcutta‚ 2015 Industries follow distinctive
Premium Harvard Business School Strategic management Harvard University
Project Paper Summary Nucleon Inc. was founded in 1985 by Dr. Alan Ball. From 1985 until 1988 Dr. Ball and a small group of scientists researched ways of producing CRP-1 outside the body. CRP-1 is a cell regulating protein which Nucleon Inc. believed would be effective at treating burn wounds and acute kidney failure. In the field of biotechnology there was intense competition in R&D and patent protection. Nucleon believed it had a strong patent position on the CRP-1 molecule; its rights to
Premium Fixed cost Cost Pharmaceutical industry
HOW SUPPLY CHAIN VISIBILITY CAN CHANGE THE FACE OF CLINICAL TRIALS October 2012 When it comes to clinical trials‚ many pharmaceutical companies seem to be lacking something. Opportunities to make financial and time saving benefits are not being taken. And yet easy to initiate solutions are now available that can affect genuine change. Often discussed but rarely seen in action‚ clinical trials supply chain visibility looks set to significantly improve the entire clinical trials process. Everything
Premium Clinical trial Pharmaceutical industry Clinical research
stresses during their manufacturing‚ distribution and handling by the end-user. During the process of coating‚ transportation‚ packing and processing tablet‚ tablet will lose some weight. Because of that‚ the friability test is performed in the pharmaceutical industry to test the tendency of a tablet breaking into smaller pieces during transit. It includes repeatedly dropping a sample of tablets over a fixed time by using friability tester and then checking whether any tablets are broken‚ and calculate
Premium Tablet Mathematics Pharmaceutical industry
the clinical practice of psychiatry is briefly reviewed. Then the possible involvement of these pharmacogenomic tests in the exploration of early clinical proof of mechanism is described by using two of the tests and one example from the pharmaceutical industry (iloperidone clinical trials). The initial attempts to use other microarray tests (measuring RNA expression) as peripheral biomarkers for CNS disorders are briefly described. Then the challenge of taking pharmacogenomic tests (compared to
Premium Pharmacology Clinical trial Pharmaceutical industry
Genentech: After the Acquisition by Roche Strategic Management June 2014 Introduction Roche completed the acquisition of Genentech in 2009 for a total of $46.8 Billion dollars. Genentech was initially concerned about funding for early drug discovery with the acquisition taking place. Genentech was previously able to spend money on research and development for new drug discovery and now that Roche is fully in the picture‚ they were concerned that Roche may want to reduce funding for
Premium Pharmaceutical industry Pharmacology Drug development
(1) Brief Chronology 5/23/2010- Sanofi’s CEO Chris Viehbacher approaches Genzyme’s CEO Henri Termeer about an acquisition. Termeer expresses interest but wishes to discuss the possible deal after the company’s shareholder meeting in June. 6/28/2010- Viehbacher calls Termeer to set up a meeting and Termeer promises to respond soon. 7/2/2010- The media becomes alerted about Sanofi wishing to purchase a U.S. biotech company as rumors circulate about Genzyme. 7/29/2010- Sanofi
Premium Pharmaceutical industry Stock market Stock
Rural Entrepreneurship through Agro-Processing Industries Mrs. P. Geetha‚ Lecturer in Economics‚ Sri GVG Visalakshi College for Women‚ Udumalpet‚ TamilNadu‚ India In India there are about 6.3 million villages and 340 million workers in rural unorganized sector who contribute 60% of national income. About 75% of populations who live in villages have to utilize the village resources. In rural areas mainly three types of economic activities are being undertaken. These activities are: primary
Premium Economics Industry
INDUSTRY OVERVIEW The Indian Industry as a whole has given away a growth which is of positive but comparatively less than the previous year. For instance the Industry registered a growth of 7% in the month of April 2008 as compared to 11% growth registered in the same month of the previous year. In March 2008 industrial growth which was recorded was 3.9% the lowest in past 6 years. The growth slipped due to the sharp downfall in the manufacturing and specifically electrical sector to 7.5% and
Premium Cotton Textile Textile manufacturing